Suh, Young Sun <br/><br/>
Safe re-administration of tumor necrosis factor-alpha (TNFα) inhibitors in patients with rheumatoid arthritis or ankylosing spondylitis who developed active tuberculosis on previous anti-TNFα therapy.  [electronic resource] 

 -  Journal of Korean medical science  Jan 2014 
 - 38-42 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1598-6357 
<br/><br/><label>Standard No.: </label>10.3346/jkms.2014.29.1.38  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adalimumab<br/>Adult<br/>Aged<br/>Anti-Inflammatory Agents, Non-Steroidal--adverse effects<br/>Antibodies, Monoclonal--adverse effects<br/>Antibodies, Monoclonal, Humanized--adverse effects<br/>Antirheumatic Agents--adverse effects<br/>Arthritis, Rheumatoid--drug therapy<br/>Enzyme Inhibitors--adverse effects<br/>Etanercept<br/>Female<br/>Humans<br/>Hydroxychloroquine--adverse effects<br/>Immunoglobulin G--adverse effects<br/>Immunosuppressive Agents--adverse effects<br/>Infliximab<br/>Interferon-gamma Release Tests<br/>Male<br/>Methotrexate--adverse effects<br/>Middle Aged<br/>Mycobacterium tuberculosis--isolation & purification<br/>Receptors, Tumor Necrosis Factor--therapeutic use<br/>Retrospective Studies<br/>Spondylitis, Ankylosing--drug therapy<br/>Tuberculin Test<br/>Tuberculosis--chemically induced<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors